^
    Back
    Association details:
    Biomarker:JARID2 overexpression
    Cancer:Glioma
    Drug:temozolomide (DNA synthesis inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: D – Preclinical
    Source:
    Cancer Biol Ther
    Title:

    The function and mechanism of the JARID2/CCND1 axis in modulating glioma cell growth and sensitivity to temozolomide (TMZ)

    Published date:
    07/12/2021
    Excerpt:
    JARID2 overexpression significantly inhibited glioma cell viability, promoted glioma cell apoptosis upon TMZ treatment.
    DOI:
    10.1080/15384047.2021.1942711